Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Le Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5610-2343; OpenAlex author ID A5076618597, A5130578638. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 9

  1. Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Induced Neutrophil Extracellular Trap Format… Co-author DOI 10.1158/0008-5472.can-25-2854↗
  2. Correction: UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. First author DOI 10.1186/s13046-026-03696-5↗
  3. Alcohol-induced C/EBP β-driven VIRMA decreases oxidative stress and promotes pancreatic ductal adenocarcinoma growth and metastasis via the m6A/YTHDF2/SLC43A2 … Co-author DOI 10.1038/s41388-025-03283-6↗
  4. DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2023.216288↗
  5. CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-22-2553↗
  6. Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer. Last author DOI 10.1186/s12967-023-04693-4↗
  7. Alcohol-induced C/EBP β-driven KIAA1429 decreases oxidative stress and promotes pancreatic cancer growth and metastasis via the m6A/YTHDF2/SLC43A2 pathway Co-author DOI 10.21203/rs.3.rs-1721317/v1↗
  8. Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. Co-author DOI 10.3389/fonc.2021.630972↗
  9. Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer. Co-author DOI 10.18632/oncotarget.12365↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gang Wang · 5 shared papers, 2016–2026 · strength 0.86
  2. Rui Kong · 4 shared papers, 2016–2026 · strength 0.60
  3. Yongwei Wang · 4 shared papers, 2016–2026 · strength 0.57
  4. Guanqun Li · 3 shared papers, 2021–2026 · strength 0.52
  5. Wenbo Yang · 3 shared papers, 2021–2023 · strength 0.44
  6. Hongze Chen · 2 shared papers, 2023–2026 · strength 0.42
  7. Bei Sun · 2 shared papers, 2023–2026 · strength 0.42
  8. Yan Luo · 2 shared papers, 2023–2026 · strength 0.39
  9. Jisheng Hu · 2 shared papers, 2023–2026 · strength 0.39
  10. Bei Sun · 2 shared papers, 2021–2026 · strength 0.36
  11. Bei Sun · 3 shared papers, 2016–2023 · strength 0.35
  12. Hongze Chen · 3 shared papers, 2016–2023 · strength 0.34
  13. Shangha Pan · 2 shared papers, 2016–2026 · strength 0.32
  14. Liwei Liu · 2 shared papers, 2023 · strength 0.31
  15. Xinglong Geng · 2 shared papers, 2021–2023 · strength 0.28
  16. Chundong Cheng · 1 shared paper, 2026 · strength 0.27
  17. Lei Gao · 1 shared paper, 2025 · strength 0.27
  18. Yuhua Zhang · 1 shared paper, 2025 · strength 0.27
  19. Zhongjie Zhao · 2 shared papers, 2016–2023 · strength 0.21
  20. Yangyang Zhang · 1 shared paper, 2023 · strength 0.15
  21. Danxi Liu · 1 shared paper, 2023 · strength 0.15
  22. Qiushi Tang · 1 shared paper, 2022 · strength 0.15
  23. Yang Zhang · 1 shared paper, 2021 · strength 0.13
  24. Tao Zhang · 1 shared paper, 2021 · strength 0.13
  25. Dafna Bar‐Sagi · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.